If you or someone you love has taken Zantac or any of the corresponding generic forms, you may be entitled to compensation. The manufacturers have recalled the drug due to links with deadly diseases. We have been going up against large corporations for years and are ready to fight for you.
What is Zantac?
Zantac is a popular over-the-counter medication used to prevent and treat heartburn and indigestion. It is the brand name of ranitidine sold by the pharmaceutical company Sanofi, although they aren’t the only company to manufacture ranitidine. Many generic versions of the drug have appeared in pharmacies and convenience stores throughout the world. It has been around since 1981 and grew to more than 15 million prescriptions by 2016.
Why Was Zantac Recalled?
A recent study found various versions of ranitidine, including Zantac, contain N-nitrosodimethylamine (NDMA). NDMA is an environmental contaminant and is classified as a probable carcinogen—a substance that can cause cancer. This testing showed that a tablet of Zantac contained 26,000 times the FDA’s acceptable daily limit of NDMA.
NDMA has been associated with a number of harmful conditions including:
- Bladder cancer
- Stomach cancer
- Kidney cancer
- Colon cancer
- Pancreatic cancer
- Liver cancer
Lawsuits have started to be filed, both class action and individual cases, against the makers of this drug. The upcoming months will surely see the amount of these lawsuits skyrocket as more information comes out.
If you or a member of your family has suffered from bladder cancer or any of the other listed consequences of NDMA consumption, call Bart Durham Injury Law.